Renal Denervation Systems Market
完整報告名稱與涵蓋範圍
Renal Denervation Systems Market Size, Share & Trends Analysis Report, By Technology (Radiofrequency Renal Denervation, Ultrasound Renal Denervation, Alcohol-Mediated and Other Chemical Denervation, Emerging Energy Modalities), By Indication (Uncontrolled and Resistant Hypertension, Hypertension with Cardiovascular Comorbidities, Emerging Indications (Heart Failure, Arrhythmia, Metabolic Disease)), By End User (Hospitals and Interventional Cardiology Centers, Specialty Hypertension Clinics), By Region, and Segment Forecasts, 2026-2035
報告摘要
The renal denervation systems market covers catheter-based devices that ablate renal sympathetic nerves using radiofrequency, ultrasound, alcohol infusion or emerging energy modalities to lower blood pressure in patients with uncontrolled or resistant hypertension, including generators, catheters and procedural consumables. Antihypertensive drugs and non-invasive blood pressure monitoring are excluded but analysed as the treatment context.
After a decade of clinical setbacks and re-engineering, sham-controlled trials demonstrated consistent blood pressure reductions, leading to regulatory approvals in the United States and the establishment of national coverage, which has reopened the commercial opportunity. Adoption now depends on building referral pathways from hypertension specialists and primary care, on patient selection tools, on procedural reimbursement and on evidence in populations such as chronic kidney disease, heart failure and atrial fibrillation where sympathetic modulation may add value. Chinese manufacturers have advanced domestic systems through large trials, and next-generation devices aim to reduce procedure time and confirm nerve ablation intra-procedurally.
North America and Europe lead approvals and reimbursement, while China represents the largest patient pool with domestic approvals expanding access; Japan and South Korea follow. Competition involves two established global systems, Chinese domestic developers and innovators with alternative energy approaches.
The InsightAce study provides US$ revenue forecasts for every technology, indication and end user and regional segment over 2026-2035, plus segment trend analysis, competitive landscape mapping and profiles of leading participants.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Renal Denervation Systems Market Snapshot
Chapter 4. Global Renal Denervation Systems Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Technology Estimates & Trend Analysis
5.1. Technology & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Technology:
5.2.1. Radiofrequency Renal Denervation
5.2.2. Ultrasound Renal Denervation
5.2.3. Alcohol-Mediated and Other Chemical Denervation
5.2.4. Emerging Energy Modalities
Chapter 6. Market Segmentation 2: By Indication Estimates & Trend Analysis
6.1. Indication & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Indication:
6.2.1. Uncontrolled and Resistant Hypertension
6.2.2. Hypertension with Cardiovascular Comorbidities
6.2.3. Emerging Indications (Heart Failure, Arrhythmia, Metabolic Disease)
Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. End User & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
7.2.1. Hospitals and Interventional Cardiology Centers
7.2.2. Specialty Hypertension Clinics
Chapter 8. Renal Denervation Systems Market: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. United States
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. United Kingdom
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia Pacific
8.3.1. China
8.3.2. Japan
8.3.3. India
8.3.4. South Korea
8.3.5. Australia
8.3.6. Southeast Asia
8.3.7. Rest of Asia Pacific
8.4. Latin America
8.4.1. Brazil
8.4.2. Mexico
8.4.3. Rest of Latin America
8.5. Middle East & Africa
8.5.1. GCC Countries
8.5.2. South Africa
8.5.3. Rest of Middle East & Africa
Chapter 9. Competitive Landscape
9.1. Company Market Positioning Analysis
9.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 10. Company Profiles
10.1. Medtronic plc
10.2. Recor Medical, Inc. (Otsuka Holdings)
10.3. SyMap Medical (Suzhou) Ltd.
10.4. Shanghai Golden Leaf MedTec Co., Ltd.
10.5. Ablative Solutions, Inc.
10.6. SoniVie Ltd.
10.7. Kalos Medical
10.8. Terumo Corporation (Distribution Partnerships)
10.9. Shanghai Anke Medical
10.10. Suzhou Xinmai Medical
10.11. Verve Medical, Inc.
10.12. Boston Scientific Corporation
10.13. Abbott Laboratories
10.14. Beijing Wanjie Medical
10.15. Hangzhou Nuomao Medtech
圖表清單 List of Tables & Figures
Table 1. Global Renal Denervation Systems Market Revenue Forecast by Technology, 2026-2035 (US$ Mn)
Figure 1. Global Renal Denervation Systems Market Segmentation Overview
Table 2. Global Renal Denervation Systems Market Revenue Forecast by Indication, 2026-2035 (US$ Mn)
Figure 2. Global Renal Denervation Systems Market Share by Technology, 2026 & 2035
Table 3. Global Renal Denervation Systems Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 3. Renal Denervation Clinical Evidence Timeline and Reimbursement Milestones by Region
Table 4. North America Renal Denervation Systems Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 4. Global Renal Denervation Systems Market Share by Indication, 2026 & 2035
Table 5. Europe Renal Denervation Systems Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Hypertension Patient Funnel from Uncontrolled Diagnosis to Procedural Candidacy
Table 6. Asia Pacific Renal Denervation Systems Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Asia Pacific Renal Denervation Systems Growth Opportunity Analysis
Table 7. Latin America Renal Denervation Systems Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Energy Modality Comparison: Radiofrequency, Ultrasound and Alcohol-Mediated Denervation
Table 8. Middle East & Africa Renal Denervation Systems Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Competitive Positioning of Key Renal Denervation Systems Market Participants
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們